Pneumotox Online
v2.2
  • RSS Feed
  • Contact
  • News
  • Diagnosing DIRD
  • Browse
  • Available on AppStore Available on AppStore

The Drug-Induced Respiratory Disease Website

Philippe Camus, M.D.

Dijon, France

  • Home
  • Browse by »
  • Drugs
  • Patterns

Ibuprofen

3

VI.y Pulmonary hypertension of the newborn (Persistent PHT)

1
Last update : 04/03/2016
 
Search
Advanced search
Identify causative drugs
Diagnosing DIRD
1
Drug and radiation history
2
Drug singularity - Correct identification of the drug
3
Consistent timing of exposure v. onset of symptoms
4
Clinical, imaging, BAL, pathological pattern consistent with the specific drug
5
Careful exlusion of another cause
6
Remission of symptoms with removal of drug
7
Recurrence with rechallenge (rarely advisable)
8
Causality assessment
More detailed checklist
See also under
Nonsteroidal anti-inflammatory drugs (NSAIDs)
5

Publications

Pulmonary Arterial Hypertension after Ibuprofen Treatment for Patent Ductus Arteriosus in Very Low Birth Weight Infants.
The Journal of pediatrics 2016 Dec;179;49-53.e1 2016 Dec
Lethal pulmonary hypertension associated with ibuprofen treatment in a very low birth weight infant.
Journal of paediatrics and child health 2014 Jan;50;85-6 2014 Jan
Severe pulmonary hypertension with therapeutic L-lysine ibuprofen in 2 preterm neonates.
Pediatrics 2012 May;129;e1360-3 2012 May
Pulmonary hypertension following L-lysine ibuprofen therapy in a preterm infant with patent ductus arteriosus.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2006 Jun 20;174;1843-4 2006 Jun 20

Powered by

  • ^
  • Contact
  • Cookies
  • About

The Pneumotox website uses cookies. By accessing or using our website, you consent to the collection, use and disclosure of the garnered information in accordance with our privacy policy.

Learn more about cookies